Biocon's total income stands at Rs 592 cr, net profit Rs 74 cr in Q2
Biocon Ltd has posted a net profit of Rs 74 crore for the Q2 ended September 30, 2009 which includes earnings from its German subsidiary AxiCorp. The year-on-year growth was 192 per cent which is up by 47 per cent YoY. This is nearly a three-fold jump over the same period last year posted mainly by its clinical research organizations namely Syngene and Clinigene.
Consolidated total income of the company rose to Rs 592.35 crore during the September quarter from Rs 457.73 crore in the same period of the previous year. On a standalone basis, the company posted a whopping 86 per cent jump in second quarter net profit at Rs 62.36 crore. The total income during the second quarter increased to Rs 312.44 crore as against Rs 268.27 crore achieved in the same period of the previous year.
Comments